The Billion-Dollar Misalignment

I. The Clinical Failure: Waiting for the Alarm

The COVID-19 pandemic exposed a critical flaw in the modern, digitized U.S. healthcare system: our inability to conduct real-time, self-generated safety surveillance.

Consider the case of myocarditis following mRNA vaccination. Large hospital systems, utilizing sophisticated Electronic Health Records (EHRs) like Epic and Cerner, vaccinated millions of patients. If a patient presented with new-onset myocarditis days or weeks later, that information—the vaccination date, the diagnosis, and the patient demographics—was captured immediately and digitally.

The Failure: These immense, costly systems possess the core data necessary for immediate epidemiological tracking. Yet, healthcare systems waited. They waited for pharmaceutical companies to report aggregated trial data. They waited for governmental agencies (like the CDC and FDA) to compile voluntary, often delayed, and incomplete reports (like VAERS). We failed to leverage the data we already owned.

A simple query connecting the EHR fields for 'COVID-19 Vaccination Status' and 'Diagnosis: Myocarditis' should have served as an instant internal flag, identifying clusters or trends in specific patient populations (e.g., young males) weeks or even months before official regulatory bodies issued comprehensive warnings.

II. The Infrastructure Priority: Designed for Billing

This failure is not a technical oversight; it is a profound reflection of intentional systemic design and perverse incentives. The United States has spent billions of dollars digitizing medical records—a massive undertaking primarily driven by legislation like the HITECH Act.

The Question: Why, after this colossal investment, are our EHR systems optimized for administrative functions rather than clinical intelligence?

The Incentive: EHRs were fundamentally designed to meet two goals: billing compliance (ensuring maximum reimbursement from insurers) and regulatory compliance (documenting quality metrics).

The Result: EHRs excel at telling us what services were performed and who will pay for them. They are notoriously poor at generating new medical knowledge, identifying emerging public health threats, or answering complex research questions in real time. Knowledge generation is an accidental byproduct, not a design priority.

Critique: Our national investment built a vast digital archive intentionally optimized for accounting, leaving us functionally blind to emerging health trends within our own patient populations.

III. The Mandate: Tracking Adverse Events and Population Health

Large, integrated healthcare systems—those that care for hundreds of thousands or millions of patients—have a unique ethical and scientific mandate to lead the surveillance effort.

Internal Epidemiology: These systems should be especially tasked with proactive, automated tracking of adverse events (AEs) and side effects. This involves developing machine learning algorithms or simple automated dashboards that continuously screen the EHR for unusual correlations between treatments and subsequent diagnoses.

Turning Over Every Stone: When a trend emerges , the system must be designed to immediately flag that pattern, prompting physician-scientists to ask the crucial question: Why? This shifts the systems from passive storage units to active research engines.

A reliance solely on pharmaceutical companies or government agencies constitutes a dereliction of professional oversight by the healthcare systems themselves. The data needed to improve patient safety is already available in our systems; our challenge is to prioritize the intellectual curiosity, systemic design, and financial incentives necessary to look for it.